Article info
Colorectal neoplasia
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
- Dr S Ogino, Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, 44 Binney Street, Room JF-215C, Boston, MA 02115 USA; shuji_ogino{at}dfci.harvard.edu
Citation
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
Publication history
- Revised August 26, 2008
- Accepted September 1, 2008
- First published October 2, 2008.
Online issue publication
December 17, 2008
Article Versions
- Previous version (2 October 2008).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group & British Society of Gastroenterology